(Alliance News) - Aptamer Group PLC said on Tuesday that it has extended its contract with Unilever PLC for the development of novel Optimer binders for use in deodorant products.
The York, England-based biotechnology firm will partner with Unilever, the London-based consumer goods firm, to continue its work in testing Optimer binders as active ingredients in deodorants.
Aptamer said the use of active ingredients like Optimer binders in deodorant products is "highly novel" and "holds the potential for enhanced efficacy for customer products". Optimer binders target the C-S Lyase bacterial enzyme, which is critical in the generation of auxiliary odour.
The contract follows successful laboratory tests of the Optimer binders, allowing the partnership to progress to planned in-vivo studies before the end of 2024.
Aptamer Chief Executive Officer Arron Tolley said: "The continued advancement of our Optimer binders in collaboration with Unilever is a significant milestone for Aptamer Group. With efficacy testing on the horizon, we are optimistic about bringing these binders to market in the coming years and look forward to discussing commercial opportunities with Unilever upon successful trial outcomes."
Aptamer Group share prices were up 8.7% to 0.25 pence each in London on Tuesday morning.
By Emily Parsons, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.


LONDON, July 1 (Reuters) - A rush of foreign bids for UK companies has put Britain on track to outstrip all previous records for dealmaking in 2026,...


* Thorne attracted strategic interest, including a bid from Haleon, sources say


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:


Levi Strauss will limit items for holiday shopping season *


(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:


AstraZeneca is London market's most valuable listed company *


(Sharecast News) - London stocks finished higher on Friday, lifted by renewed optimism over a potential US-China trade agreement as investors digested...


(Alliance News) - Stock prices in London opened higher on Friday, ahead of personal consumption expenditure data from the US.


(Alliance News) - London stocks were called higher on Friday, following reports that the US and China have reached an understanding on trade issues, i...


(Sharecast News) - The sale price of Unilever's takeover of men's grooming brand Dr Squatch is reported to have been $1.5bn, according to reports on F...


(Alliance News) - Unilever PLC is paying USD1.5 billion for its acquisition of Dr Squatch, a maker of male grooming products, the Financial Times repo...